Daily Archives: December 27, 2017

CTCA Joins Forces with Reputable WebMD to Spread Cancer Education

Cancer Treatment Centers of America work hard every day to assist their cancer patients in their hard fight. Oncology is the field that studies cancers. These oncology treatments change rapidly as new research brings new understanding and alternative treatments, drugs and more cancer related opportunities. CTCA is made up of an impressive array of cancer care specialists who all play a critical part in each patient’s very personalized cancer battle. CTCA is tireless in their efforts to keep the public educated with new details about cancer subjects. Now, CTCA is working together with WebMD to get more information on cancer care out to more people in a fast method.

WebMD is the standard for online trustworthy medical sites. They seek to educate, and their articles are all somehow related to healthcare. Cancer Treatment Centers of America is allowing WebMD to publish some of the information they have recently acquired. This joint medical education effort is hoped to lower mortality deaths from advanced cancer due to lack of knowledge. Fast diagnosis and appropriate early treatment are the two greatest factors in how the patient will respond. It is sad that so many are not diagnosed until their illness is too far reaching to effectively treat.

Many forms of cancer spreads throughout the body systems. When this happens, treatment options become limited. Cancer Treatment Centers of America is leading the battle charge to educate everyone on certain topics that may just save lives. WebMD is one more outlet for this critically important cancer knowledge to be passed along to others. The Internet is being used by many in these times. CTCA is focused on supplying the education necessary before everyone can win their cancer battles. Cancer Treatment Centers of America post their news on their website and now on WebMD too.

To Learn More : www.myctca.com

Oncotarget: A Powerful Tool Against Cancer

Scientists around the world are working together to help fight the disease that has already claimed the lives of millions since the dawn of humanity. Dr. Mikhail Blagosklonny and Andrei V. Gudkov have developed an open-access platform for oncologists to use, called Oncotarget, which was introduced in 2010. They are hoping that by inventing a platform that would allow the oncologists to upload their findings and sending it to the system, their colleagues from the other side of the planet who knows more can check it out and formulate something useful about it. Download output styles at Endnote.com Oncologists worldwide are racing against time, and they are doing their best to create a powerful tool that can be used against cancer. They have been using several methods today including chemotherapy to fight cancer, but these methods are leaving a disastrous side effect on the patient’s body. Dr. Mikhail Blagosklonny and Andrei V. Gudkov are hoping that a better cure can be developed, and with Oncotarget, they are hoping that oncologists are brainstorming and sharing ideas that could one day result to the formulation of the cure. Learn more about Oncotarget at Eurekalert.org.

Oncotarget posts new articles online twice every week, and everyone can access the information that they publish. Oncologists are grateful about the development of the platform because they would have a better method to upload their findings, and they are thankful by the fact that even the smallest findings can be uploaded for the whole scientific community to see. Dr. Mikhail Blagosklonny and Andrei V. Gudkov, the editors in chief of Oncotarget, have also decided to shift to podcast broadcasting. According to them, every article or journal published by Oncotarget will have an audio version, to enable full readings of each study. The authors of each publication will also be given a chance to have an interview with the hosts and explain further what the findings are all about. Dr. Mikhail Blagosklonny and Andrei V. Gudkov are excited for the debut of the platform, saying that it is another highlight to the growth of Oncotarget, and they are welcoming other methods or options on how to share the articles within Oncotarget to the world.

Read more: http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid